Katherine C. Saunders

1.3k total citations
36 papers, 994 citations indexed

About

Katherine C. Saunders is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Katherine C. Saunders has authored 36 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 13 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Katherine C. Saunders's work include Rheumatoid Arthritis Research and Therapies (24 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Systemic Lupus Erythematosus Research (9 papers). Katherine C. Saunders is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Systemic Lupus Erythematosus Research (9 papers). Katherine C. Saunders collaborates with scholars based in United States, United Kingdom and Norway. Katherine C. Saunders's co-authors include P.J.A. HOLT, G. Nuki, Margaret R. Spitz, M.G. Davies, Joel M. Kremer, Sara S. Strom, Melissa L. Bondy, Anna V. Wilkinson, Yumei Cao and Carlos H. Bárcenas and has published in prestigious journals such as PLoS ONE, American Journal of Public Health and European Heart Journal.

In The Last Decade

Katherine C. Saunders

33 papers receiving 946 citations

Peers

Katherine C. Saunders
Haijun Tian United States
Thomas V. Jones United States
Margaret Hastings United States
Jonathan S. Hausmann United States
David Chandler United Kingdom
Elizabeth D. Ferucci United States
W. Benjamin Nowell United States
Yvonne E. Chiu United States
Haijun Tian United States
Katherine C. Saunders
Citations per year, relative to Katherine C. Saunders Katherine C. Saunders (= 1×) peers Haijun Tian

Countries citing papers authored by Katherine C. Saunders

Since Specialization
Citations

This map shows the geographic impact of Katherine C. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine C. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine C. Saunders more than expected).

Fields of papers citing papers by Katherine C. Saunders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine C. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine C. Saunders. The network helps show where Katherine C. Saunders may publish in the future.

Co-authorship network of co-authors of Katherine C. Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine C. Saunders. A scholar is included among the top collaborators of Katherine C. Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine C. Saunders. Katherine C. Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saunders, Katherine C., et al.. (2024). National and interprovincial prescribing patterns of JAK-inhibitors in Canada: a repeated cross-sectional analysis. Clinical Rheumatology. 43(10). 3083–3088.
2.
Lillegraven, Siri, Jeffrey D. Greenberg, George Reed, et al.. (2019). Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis. PLoS ONE. 14(1). e0210459–e0210459. 39 indexed citations
3.
Harrold, Leslie R., Heather J. Litman, Katherine C. Saunders, et al.. (2018). One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry. Arthritis Research & Therapy. 20(1). 2–2. 26 indexed citations
4.
Reed, George, David H. Collier, Andrew Koenig, et al.. (2017). Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis. Arthritis Research & Therapy. 19(1). 81–81. 7 indexed citations
5.
Strand, Vibeke, Paul Miller, Setareh A. Williams, et al.. (2017). Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry. Rheumatology and Therapy. 4(2). 489–502. 46 indexed citations
6.
Kavanaugh, Arthur, Edward Keystone, Jeffrey D. Greenberg, et al.. (2017). Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry. Lara D. Veeken. 56(7). 1095–1101. 13 indexed citations
7.
Harrold, Leslie R., George Reed, Joel M. Kremer, et al.. (2016). Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations. Arthritis Research & Therapy. 18(1). 94–94. 6 indexed citations
8.
Pappas, Dimitrios A., George Reed, Katherine C. Saunders, et al.. (2015). Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population. Rheumatology and Therapy. 2(1). 85–96. 15 indexed citations
9.
Strand, Vibeke, Jeffrey D. Greenberg, Jenny Griffith, et al.. (2015). Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry. Arthritis Care & Research. 68(7). 914–921. 6 indexed citations
10.
Harrold, Leslie R., George Reed, J. Timothy Harrington, et al.. (2015). AB0286 A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-To-Target Approach in the Clinical Care of Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases. 74. 988–989. 4 indexed citations
12.
Harrold, Leslie R., George Reed, J. Timothy Harrington, et al.. (2014). The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network. BMC Musculoskeletal Disorders. 15(1). 389–389. 10 indexed citations
13.
Krathen, Michael, George Reed, Hong Chang, et al.. (2014). A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort. Arthritis & Rheumatology. 66(6). 1472–1481. 50 indexed citations
15.
Strand, Vibeke, Jeffrey D. Greenberg, Yanjun Bao, et al.. (2014). FRI0101 Assessing the Impact of BIOLOGICS Treatment on Use of Mechanical Devices/Aids by Rheumatoid Arthritis (RA) Patients Using A Large US Patient Registry. Annals of the Rheumatic Diseases. 73. 417–418.
16.
17.
Strand, Vibeke, Setareh A. Williams, Paul S.J. Miller, et al.. (2013). OP0064 Discontinuation of Biologic Therapy in Rheumatoid Arthritis (RA): Analysis from the Consortium of Rheumatology Researchers of North America (CORRONA) Database. Annals of the Rheumatic Diseases. 72. A71–A72. 9 indexed citations
18.
Wilkinson, Anna V., Michelle K. McHugh, Katherine C. Saunders, et al.. (2010). The Advantage of Imputation of Missing Income Data to Evaluate the Association Between Income and Self-Reported Health Status (SRH) in a Mexican American Cohort Study. Journal of Immigrant and Minority Health. 13(6). 1099–1109. 15 indexed citations
19.
Bárcenas, Carlos H., Anna V. Wilkinson, Sara S. Strom, et al.. (2007). Birthplace, Years of Residence in the United States, and Obesity Among Mexican‐American Adults. Obesity. 15(4). 1043–1052. 139 indexed citations
20.
Wilkinson, Anna V., Margaret R. Spitz, Sara S. Strom, et al.. (2005). Effects of Nativity, Age at Migration, and Acculturation on Smoking Among Adult Houston Residents of Mexican Descent. American Journal of Public Health. 95(6). 1043–1049. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026